MedPath

Leveraging Chatbot to Improve PrEP in the Southern United States

Not Applicable
Not yet recruiting
Conditions
HIV Prevention
PrEP Awareness
PrEP Uptake
Interventions
Device: A chatbot designed to promote PrEP awareness and uptake for Black MSM
Other: General educational messages
Registration Number
NCT05968755
Lead Sponsor
Yale University
Brief Summary

The purpose of this study is to develop a chatbot intervention to promote PrEP awareness and uptake among Black men who have sex with men (MSM) in the Southern United States.

Detailed Description

In the United States (US), the epicenter of the HIV epidemic is in the South. The HIV-related death rate in the US South is high, but engagement with quality HIV prevention services and care is low. Although only 38% of the US population lives in the South, the region accounts for 51% of new HIV infections. Gay, bisexual, and other men who have sex with men (MSM) account for 60% of new infections among African Americans in the South. Black MSM are one of the most vulnerable groups to HIV transmission in the US. HIV testing and PrEP uptake in Black MSM, however, remain low (10%) due to multiple factors including stigma, sexual-orientation based discrimination and low PrEP awareness among Black MSM. Innovative strategies that motivate and provide guidance for PrEP among Black MSM in the US South are therefore urgently needed. Chatbot technology should be tested and implemented to help improve PrEP awareness and uptake in the US South. In this project, the investigators aim to develop and pilot test to assess the acceptability and feasibility of a chatbot for PrEP awareness and uptake relative to treatment as usual (control).

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
Male
Target Recruitment
145
Inclusion Criteria
  • Being cisgender Black male
  • Being aged ≥ 18 years
  • Having Internet access
  • Speaking English
  • Self-reporting condomless sex with another man in the past 6 months
  • HIV negative or untested.
Exclusion Criteria
  • Having lived in the US South less than 3 months
  • Having received antiretroviral therapy (ART) treatment.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention groupA chatbot designed to promote PrEP awareness and uptake for Black MSM-
Control groupGeneral educational messages-
Primary Outcome Measures
NameTimeMethod
Change from baseline PrEP uptake in 90 daysAt baseline, 30 days, 60 days, and 90 days

PrEP uptake will be measured as the mean of the frequency of taking PrEP medication. Specifically, the investigators will collect PrEP uptake by asking participants through a Qualtrics survey if they have been taken PrEP at baseline and every 30 days. If participants respond that they have taken PrEP, the investigators will ask them the date and frequency of taking it and ask them to upload a photo of their PrEP for verification to reduce social desirability bias in responses.

Change from baseline PrEP awareness in 90 daysAt baseline, 30 days, 60 days, and 90 days

PrEP awareness will be measured as the proportion of participants who are aware of PrEP. Specifically, the investigators will collect PrEP awareness by asking participants standardized questions through a Qualtrics survey.

Secondary Outcome Measures
NameTimeMethod
Change in Usability scoreAt baseline, 30 days, 60 days, and 90 days

The usability score will be measured by the System Usability Scale, which is 5-point Likert scale consisted of 10 questions. Participants' scores range from 0 to 100. A score of 68 is average, below 68 is poor, above 68 is good, and above 80.3 is excellent.

Change in Practicality scoreAt baseline, 30 days, 60 days, and 90 days

Practicality defined as the extent to which the chatbot provides real-time Self-Determination theory inputs, will be measured using a 5-point Likert question "How would you rate the overall quality of the chatbot?"

Change in Acceptability scoreAt baseline, 30 days, 60 days, and 90 days

Acceptability, defined as the extent to which the chatbot is suitable and satisfactory to MSM, will be measured using the standardized Customer Satisfaction Scale "How would you rate your overall satisfaction with the chatbot?" and a 5-point Likert question "How would you rate the likelihood of continuing to use the chatbot?"

Change in Recommendation scoreAt baseline, 30 days, 60 days, and 90 days

The recommendation score will be calculated by a Net Promote Score, which measures MSM's likelihood to recommend the chatbot to other MSM friends. The score ranges from 0 to 10. The higher the score, the better the recommendation score.

Change in Demand scoreAt baseline, 30 days, 60 days, and 90 days

Demand, defined as the level of integration to which the chatbot fits into the MSM-preferred online platform, will be measured by the number of actual use documented on developer's platform.

Change in Adaptation scoreAt baseline, 30 days, 60 days, and 90 days

Adaptation, defined as the extent to which the chatbot can be integrated into other social-networking apps, will be measured by asking "How likely would you use the chatbot if embedded on other apps?"

Trial Locations

Locations (4)

Care 4 U Community Health Center

🇺🇸

Miami, Florida, United States

Community Care Resources of FL (CCRSFL)

🇺🇸

Pembroke Pines, Florida, United States

RAO Community Health

🇺🇸

Charlotte, North Carolina, United States

NAESM, Inc

🇺🇸

Atlanta, Georgia, United States

© Copyright 2025. All Rights Reserved by MedPath